Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) happens to be one of those that will make presentations at the Raymond James Human Health Innovation Conference. The event is set for June 23, 2021, at 8:00 a.m. ET.
The company’s precedent one of those making presentations
This progressive clinical-stage biopharmaceutical company discloses the President and Chief Executive Officer Seth Lederman will represent it in the game-changing event. Most investors look forward to listening to the top official who will make presentations during the event.
It is a decisive moment for all investors, and the flexibility is pretty outstanding. It is good that all those investors who want to participate in the virtual meeting will get the opportunity to do so. It will, however, be important that they make the proper arrangements in advance. For example, they might have to contact the Raymond James conference coordinator to get the assistance and direction they need.
The arrangements happen to be rather elaborate, and the one way to look at the whole thing is the availability of a webcast of the presentation under the IR Events tab of the Investors section of the Tonix website.
The company continues channeling resources towards facilitating the discovery, acquisition, and licensing of biologics and small molecules to facilitate the treatment of a myriad of human diseases. It also targets to minimizes suffering among humans significantly.
The company takes great pride in its elaborate portfolio, consisting of diverse immunology product candidates and the central nervous system (CNS).
The other interesting attribute about the company happens to be its CNS portfolio comprising of tiny molecules that aid the treatment of psychiatric, neurologic, and addiction conditions.